Clinical trial
High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer…
NCT00002465 · St. Vincent Medical Center - Los Angeles, Other · Unknown status
Key facts
| NCT number | NCT00002465 |
|---|---|
| Title | High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma |
| Official title | Phase I/II Study of High-Dose Megestrol in Breast or Endometrial Carcinoma or Mesothelioma |
| Lead sponsor | St. Vincent Medical Center - Los Angeles, Other |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Endometrial Cancer, Malignant Mesothelioma |
| Intervention type | Drug |
| Interventions | megestrol acetate |
| Start date | Dec 1, 1987 |
| First posted | Jul 19, 2004 |
| Last update posted | Nov 6, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: